Cubist Pharmaceuticals, Inc. (CBST) Tops Q3 EPS by 10c
Tweet
Share
E-mailGet Alerts CBST Hot Sheet
Price: $101.94 --0%
Financial Fact:
Diluted net (loss) income per common share (in shares): 86M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Diluted net (loss) income per common share (in shares): 86M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) reported Q3 EPS of $0.55, $0.10 better than the analyst estimate of $0.45. Revenue for the quarter came in at $238.2 million versus the consensus estimate of $240.04 million.
For earnings history and earnings-related data on Cubist Pharmaceuticals, Inc. (CBST) click here.
For earnings history and earnings-related data on Cubist Pharmaceuticals, Inc. (CBST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- Wendy's U.S. president to resign, company to create COO role
- Duos Technologies Group, Inc. (DUOT) Tops Q2 EPS by 163c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
